Peptide therapy for hair and glow: hype vs. actual evidence

What did @taaydsouza actually say?

@taaydsouza told 1.2 million viewers that GHK-Cu gave her visibly new hair growth, thicker and fuller hair, glowing skin, and cleared her eczema. Her exact words: "my eczema is cleared" and "I just cannot say enough good things about GHK-Cu." She presented these as personal proof that the peptide works, pointing to new growth at her hairline on camera.

To be fair, she did not prescribe a dose, name a brand, or tell anyone how to inject anything. She framed it as a personal experience. That is the most defensible version of this kind of content. But 1.2 million people watching someone say a peptide cleared a chronic inflammatory skin condition is not a neutral anecdote. It functions as a health claim whether she intends it to or not.

Does the science back this up?

There is real, peer-reviewed science behind GHK-Cu, but it is mostly preclinical or small-scale. The hair growth evidence is the most credible part of what she said. The eczema claim is where the science gets thin fast.

GHK-Cu (copper tripeptide-1) has been studied for wound healing, skin repair, and hair follicle stimulation since the 1970s, when Loren Pickart first identified its activity. A 1993 study by Uno and colleagues demonstrated increased hair follicle size in animal models with GHK-Cu application. More recently, research published in Archives of Dermatological Research (Pickart et al., 2015) summarized evidence that GHK-Cu upregulates collagen synthesis and activates hair follicle genes including those in the Wnt signaling pathway. A 2018 paper in Biomolecules by Pickart and Margolina reviewed its broader regenerative properties. These are real findings. The problem is that most are in vitro, in animal models, or observational. Randomized controlled trials in humans are sparse. The eczema claim has almost no published support specific to GHK-Cu.

What did they get wrong (or right)?

She got the hair growth angle approximately right in direction, but wrong in certainty. The science supports a plausible mechanism for hair follicle stimulation. Claiming visible new growth at four to eight weeks is within the range of what pilot studies suggest is possible. Give her partial credit there.

The eczema claim is a different story. Saying "my eczema is cleared" implies GHK-Cu resolved a chronic inflammatory skin condition. Eczema has multiple subtypes, triggers, and comorbidities. There is no published clinical trial showing GHK-Cu clears eczema. There is evidence it has anti-inflammatory properties in cell culture, and a study by Hong et al. in Journal of Investigative Dermatology (2001) showed it suppressed inflammatory cytokines in skin models. But anti-inflammatory activity in a lab dish is not the same as clearing eczema in a human. She is presenting a personal outcome as if it is a repeatable, predictable result. That is the core problem with this video.

• Hair thickening claim: plausible, some supporting preclinical and small human data
• Skin glow claim: plausible, collagen-related mechanisms are reasonably supported
• Eczema cleared claim: no clinical trial evidence, significant overreach

What should you actually know?

GHK-Cu is not a fringe compound. It appears in topical cosmeceuticals and is being researched in wound care and anti-aging contexts. The peptide does have real biological activity. But there is a significant gap between "biologically active" and "will clear your eczema."

If you have eczema, the standard of care involves identifying triggers, using prescribed topical corticosteroids or newer biologics like dupilumab for moderate to severe cases. Replacing that pathway with an unregulated peptide based on a TikTok before-and-after is not a safe trade. Beyond that, GHK-Cu used systemically versus topically are very different conversations, and the video does not specify administration route. Formulation, concentration, and delivery method all affect whether you are getting any active compound at all. Anyone considering peptide therapy should be working with a licensed provider who can assess their specific condition, not reverse-engineering a regimen from social media content.